These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12552344)

  • 41.
    Mowday AM; Copp JN; Syddall SP; Dubois LJ; Wang J; Lieuwes NG; Biemans R; Ashoorzadeh A; Abbattista MR; Williams EM; Guise CP; Lambin P; Ackerley DF; Smaill JB; Theys J; Patterson AV
    Theranostics; 2020; 10(23):10548-10562. PubMed ID: 32929365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EF5 binding and clinical outcome in human soft tissue sarcomas.
    Evans SM; Fraker D; Hahn SM; Gleason K; Jenkins WT; Jenkins K; Hwang WT; Zhang P; Mick R; Koch CJ
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):922-7. PubMed ID: 16458778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 2-nitroimidazole EF5 is a biomarker for oxidoreductases that activate the bioreductive prodrug CEN-209 under hypoxia.
    Wang J; Foehrenbacher A; Su J; Patel R; Hay MP; Hicks KO; Wilson WR
    Clin Cancer Res; 2012 Mar; 18(6):1684-95. PubMed ID: 22167409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intra-articular etanercept attenuates pain and hypoxia from TMJ loading in the rat.
    Sperry MM; Yu YH; Kartha S; Ghimire P; Welch RL; Winkelstein BA; Granquist EJ
    J Orthop Res; 2020 Jun; 38(6):1316-1326. PubMed ID: 31903618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
    Dragowska WH; Warburton C; Yapp DT; Minchinton AI; Hu Y; Waterhouse DN; Gelmon K; Skov K; Woo J; Masin D; Huxham LA; Kyle AH; Bally MB
    Mol Cancer Res; 2004 Nov; 2(11):606-19. PubMed ID: 15561777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.
    Evans SM; Du KL; Chalian AA; Mick R; Zhang PJ; Hahn SM; Quon H; Lustig R; Weinstein GS; Koch CJ
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1024-31. PubMed ID: 17967299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio.
    Lehtiö K; Oikonen V; Nyman S; Grönroos T; Roivainen A; Eskola O; Minn H
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):101-8. PubMed ID: 12483416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies.
    Woods ML; Koch CJ; Lord EM
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):93-101. PubMed ID: 12118570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity.
    Koch CJ; Evans SM; Lord EM
    Br J Cancer; 1995 Oct; 72(4):869-74. PubMed ID: 7547233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors.
    Mahy P; De Bast M; Gallez B; Gueulette J; Koch CJ; Scalliet P; Grégoire V
    Radiother Oncol; 2003 Apr; 67(1):53-61. PubMed ID: 12758240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
    van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH
    J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study.
    Tran LB; Bol A; Labar D; Cao-Pham TT; Jordan B; Grégoire V; Gallez B
    Radiother Oncol; 2015 Feb; 114(2):189-94. PubMed ID: 25616539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography.
    Yapp DT; Woo J; Kartono A; Sy J; Oliver T; Skov KA; Koch CJ; Adomat H; Dragowska WH; Fazli L; Ruth T; Adam MJ; Green D; Gleave M
    BJU Int; 2007 May; 99(5):1154-60. PubMed ID: 17309552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrophilic addition of chlorine monofluoride for PET tracers.
    Kirjavainen A; Forsback S; Grönroos TJ; Haavisto L; Haaparanta M; Solin O
    Mol Imaging Biol; 2013 Apr; 15(2):131-5. PubMed ID: 22869463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
    Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ
    J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.
    Marotta D; Karar J; Jenkins WT; Kumanova M; Jenkins KW; Tobias JW; Baldwin D; Hatzigeorgiou A; Alexiou P; Evans SM; Alarcon R; Maity A; Koch C; Koumenis C
    Cancer Res; 2011 Feb; 71(3):779-89. PubMed ID: 21266355
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.